47 results
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
15 May 24
Results of Operations and Financial Condition
4:34pm
and market acceptance of Elicio’s product candidates; Elicio’s commercialization, marketing and manufacturing capabilities and strategy; Elicio’s
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
5 Apr 24
Other Events
4:33pm
that the AMP strategy can improve the potency of vaccine immunotherapy by delivering vaccine components directly to the lymph nodes, the ‘command center … candidates, including the potential for the AMP strategy to improve the potency of vaccine immunotherapy, the broad applicability of Elicio’s technology
8-K
EX-99.1
jcpaizoy36b
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
f3mv9hksa
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K
EX-99.1
nalpk o9kg
3 Nov 23
Other Events
5:10pm
8-K
EX-99.1
olw87e4deca
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
f7p19
7 Sep 23
Other Events
8:00am
8-K
EX-99.1
obol3ombvpn6wt6dl
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-99.1
771xtuq51sim gz
5 Jun 23
Other Events
8:00am
8-K
EX-99.1
p09t5hs bd
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
hrvszq j2inkvo97l
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
nl0sbm9p4v9 15suxd
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.2
zom6p
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
encj9mu
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm